Myeloid Leukaemia

Myeloid leukemia is a type of cancer that affects the blood and bone marrow, where abnormal white blood cells (myeloid cells) multiply uncontrollably. Research in this field focuses on understanding the genetic mutations that drive the development of myeloid leukemia, as well as identifying targeted therapies to treat the disease more effectively. Scientists are also investigating the role of the bone marrow microenvironment in supporting leukemia cell growth and exploring immunotherapies to harness the body's immune system against leukemia cells. Advances in cancer research have led to the development of novel drugs, such as tyrosine kinase inhibitors and monoclonal antibodies, which have shown promising results in clinical trials for patients with myeloid leukemia. However, challenges remain, including drug resistance and the need for more personalized treatment approaches based on the individual's genetic profile.